Clinical Trial Detail

NCT ID NCT02716116
Title A Trial of TAK-788 (AP32788) in Non-small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Millennium Pharmaceuticals, Inc.
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

AP32788

Age Groups: adult senior

Additional content available in CKB BOOST